Vertex Pharmaceuticals (VRTX) Net Income - Minority (2011 - 2018)

Vertex Pharmaceuticals' Net Income - Minority history runs 8 years deep, the most recent figure standing at -$28.4 million for Q3 2018.

• In Q3 2018, Net Income - Minority fell 133.13% year-over-year to -$28.4 million; the TTM figure through Sep 2018 stood at -$28.4 million (down 133.13% YoY), while the FY2017 annual figure was -$13.7 million, up 92.44% from the prior year.
• Net Income - Minority was -$28.4 million for Q3 2018 at Vertex Pharmaceuticals, up from -$28.7 million in the prior quarter.
• In the past five years, Net Income - Minority ranged from a high of -$12.2 million in Q3 2017 to a low of -$196.0 million in Q2 2017.
• Historically, Net Income - Minority has averaged -$106.9 million across 5 years, with a median of -$153.5 million in 2015.
• The sharpest annual moves came in 2016 and 2017: Net Income - Minority tumbled 654.87% in 2016, then jumped 93.49% in 2017.
• A 5-year view of Net Income - Minority shows it stood at -$21.2 million in 2014, then tumbled by 625.6% to -$153.7 million in 2015, then fell by 18.19% to -$181.6 million in 2016, then soared by 92.44% to -$13.7 million in 2017, then plunged by 106.64% to -$28.4 million in 2018.
• The last three Net Income - Minority figures came in at -$28.4 million (Q3 2018), -$28.7 million (Q2 2018), and -$29.8 million (Q1 2018), per Business Quant data.